Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Priit Ruuge"'
Publikováno v:
Life, Vol 11, Iss 2, p 170 (2021)
177Lu-DOTAGA-(l-y)fk(Sub-KuE) a.k.a. 177Lu-PSMA I&T is currently used for radioligand therapy (RLT) of metastatic castration-resistant prostate cancer (mCRPC) in several centers in Europe. Background: Dosimetry is mandatory according to EU guidelines
Externí odkaz:
https://doaj.org/article/362aa81b3b01482ab2c1b76fe61c905c
Publikováno v:
Life, Vol 11, Iss 170, p 170 (2021)
Life
Life
177Lu-DOTAGA-(l-y)fk(Sub-KuE) a.k.a. 177Lu-PSMA I&T is currently used for radioligand therapy (RLT) of metastatic castration-resistant prostate cancer (mCRPC) in several centers in Europe. Background: Dosimetry is mandatory according to EU guidelines